CON-TGO91-181 - Baxter Healthcare Pty Ltd
Product names
- AUST R 19477 - BAXTER 0.9% SODIUM CHLORIDE 450mg/50mL injection BP bag AHB1306/AHB1363
- AUST R 48515 - BAXTER 0.9% SODIUM CHLORIDE 900mg/100mL injection BP bag AHB1307/AHB1364
- AUST R 19472 - BAXTER 0.45% SODIUM CHLORIDE 500mL injection BP bag AHB1313
- AUST R 48517 - BAXTER 0.9% SODIUM CHLORIDE 2.25g/250mL injection BP bag AHB1322
- AUST R 48519 - BAXTER 0.9% SODIUM CHLORIDE 4.5g/500mL injection BP bag AHB1323
- AUST R 48520 - BAXTER 0.9% SODIUM CHLORIDE 9g/L injection BP bag AHB1324
Sponsor
Decision Date
Duration
The consent is effective for all batches manufactured from 1 September 2020 until 31 August 2021.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines